Recombinant form of MVA vaccine can be used against SARS-CoV-2 infection, reveals study ANI | Updated: Mar 13, 2021 23:13 IST
Washington DC [US], March 13 (ANI): Scientists have tracked down that modified vaccinia infection Ankara (MVA), a smallpox immunisation, can be additionally changed in a recombinant structure to communicate the spike protein of the SARS-CoV-2 infection and that injection of a couple of dosages of the recombinant MVA shielded transgenic mice from deadly infection, with vaccination also preventing detection of infectious SARS-CoV-2 in the mouse lungs.
The authors of the study were Ruikang Liu, Jeffrey L. Americo, Catherine A. Cotter, Patricia L. Earl, Noam Erez, Chen Peng, among others. The findings of the study were published in the journal PNAS.
Study sheds light on recombinant vaccine against SARS-CoV-2 in mice aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.